NCT01053442

Brief Summary

Several iron compounds are used for fortification, including ferrous sulphate and NaFeEDTA. The absorption profile of these may differ because of differences in their dissolution in the gastrointestinal tract and in their interaction with dietary inhibitors of iron absorption. As these differences might lead result in varying reactions in the blood stream, the appearance rate of the stable iron isotope, hepcidin, non-transferrin-bound iron and total iron in the plasma will be monitored over six hours in adult women. This is relevant as a spike of absorbed iron may increase non-transferrin-bound iron and this could be pro-oxidative or increase growth of pathogens. Hepcidin is a key mediator of iron absorption and will help explain the potential differences in the plasma iron profile. The use of stable iron isotope appearance curves to specifically detect the appearance of small amounts of absorbed iron in the blood and distinguish between circulating body iron and iron absorbed from the test meal was tested in a pilot study (EK 2008-23). This method is now used in a bigger sample to test the differences in absorption profile of ferrous sulphate, FePPi and NaFeEDTA given at fortification level with a meal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 21, 2010

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

April 5, 2012

Status Verified

April 1, 2012

Enrollment Period

2 months

First QC Date

January 20, 2010

Last Update Submit

April 4, 2012

Conditions

Keywords

iron absorptionstable isotopesNaFeEDTANon-transferrin-bound iron (NTBI)Hepcidin

Outcome Measures

Primary Outcomes (1)

  • Stable iron isotope appearance in the plasma over 8 hours

    day 1: 0', 30', 60', 120', 240', 480', day 8 0', 30', 60', 120', 240', 480'

Secondary Outcomes (1)

  • Isotope incorporation with erythrocytes

    day 22

Study Arms (2)

NaFeEDTA

EXPERIMENTAL

The maize porridge is fortified with 2.5mg iron as NaFeEDTA

Dietary Supplement: Porridge fortified with either NaFeEDTA

FeSO4

ACTIVE COMPARATOR

The maize porridge is fortified with 2.5 mg iron as ferrous sulphate plus ascorbic acid.

Dietary Supplement: FeSO4

Interventions

265g maize porridge is fortified with 2.5 mg iron as NaFeEDTA.

NaFeEDTA
FeSO4DIETARY_SUPPLEMENT

Maize porridge is fortified with 2.5 mg iron as ferrous sulphate and 45 mg ascorbic acid.

FeSO4

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Serum ferritin \<60 ug/ l, haemoglobin \> 100 g/ l
  • Women
  • \< 65 kg body weight
  • Healthy

You may not qualify if:

  • Pregnant or lactating
  • Taking iron supplements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratory of Human Nutrition

Zurich, Canton of Zurich, 08092, Switzerland

Location

MeSH Terms

Conditions

Iron Deficiencies

Condition Hierarchy (Ancestors)

Iron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

January 20, 2010

First Posted

January 21, 2010

Study Start

January 1, 2010

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

April 5, 2012

Record last verified: 2012-04

Locations